BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 564237)

  • 1. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
    Surya YA; Rosenfeld JM; Hillcoat BL
    Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
    Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
    Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential cytotoxicity and DNA cross-linking produced by polymeric and monomeric activated analogues of cyclophosphamide in mouse L1210 leukemia cells.
    Ramonas LM; Erickson LC; Klesse W; Kohn KW; Zaharko DS
    Mol Pharmacol; 1981 Mar; 19(2):331-6. PubMed ID: 7231393
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
    Hilton J
    Cancer Res; 1984 Nov; 44(11):5156-60. PubMed ID: 6488175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of DNA-protein cross-links formed by treatment of L1210 cells and nuclei with bis(2-chloroethyl)methylamine (nitrogen mustard).
    Thomas CB; Kohn KW; Bonner WM
    Biochemistry; 1978 Sep; 17(19):3954-8. PubMed ID: 568484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of thiourea on survival and DNA cross-link formation in cells treated with platinum(II) complexes, L-phenylalanine mustard, and bis(2-chloroethyl)methylamine.
    Zwelling LA; Filipski J; Kohn KW
    Cancer Res; 1979 Dec; 39(12):4989-95. PubMed ID: 498125
    [No Abstract]   [Full Text] [Related]  

  • 7. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
    Sladek NE; Landkamer GJ
    Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
    Hemminki K
    Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-protein cross-linking and DNA interstrand cross-linking by haloethylnitrosoureas in L1210 cells.
    Ewig RA; Kohn KW
    Cancer Res; 1978 Oct; 38(10):3197-203. PubMed ID: 150940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA cross-linking and single-strand breaks induced by teratogenic concentrations of 4-hydroperoxycyclophosphamide and phosphoramide mustard in postimplantation rat embryos.
    Little SA; Mirkes PE
    Cancer Res; 1987 Oct; 47(20):5421-6. PubMed ID: 3477317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deoxyribonucleic acid crosslinking by 4-hydroperoxycyclophosphamide in cyclophosphamide-sensitive and -resistant L1210 cells.
    Hilton J
    Biochem Pharmacol; 1984 Jun; 33(12):1867-72. PubMed ID: 6732847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of phosphoramide mustard and acrolein, cytotoxic metabolites of cyclophosphamide, on mouse limb development in vitro.
    Hales BF
    Teratology; 1989 Jul; 40(1):11-20. PubMed ID: 2763206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclophosphamide (NSC-26271)-related phosphoramide mustards- recent advances and historical perspective.
    Friedman OM; Wodinsky I; Myles A
    Cancer Treat Rep; 1976 Apr; 60(4):337-46. PubMed ID: 1277209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Observations on the effects of cyclophosphamide, phosphoramide mustard and some activated oxazaphosphorines on murine L1210 leukemia.
    Zaharko DS; Covey JM; Hörpel G
    Invest New Drugs; 1984; 2(2):149-54. PubMed ID: 6469508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
    Crook TR; Souhami RL; McLean AE
    Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA damage and repair in mouse leukemia L1210 cells treated with nitrogen mustard, 1,3-bis(2-chloroethyl)-1-nitrosourea, and other nitrosoureas.
    Ewig RA; Kohn KW
    Cancer Res; 1977 Jul; 37(7 Pt 1):2114-22. PubMed ID: 558823
    [No Abstract]   [Full Text] [Related]  

  • 17. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
    Chang TK; Waxman DJ
    Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences between melphalan and nitrogen mustard in the formation and removal of DNA cross-links.
    Ross WE; Ewig RA; Kohn KW
    Cancer Res; 1978 Jun; 38(6):1502-6. PubMed ID: 565677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of apoptosis in mediating phosphoramide mustard-induced rat embryo malformations in vitro.
    Chen B; Cyr DG; Hales BF
    Teratology; 1994 Jul; 50(1):1-12. PubMed ID: 7974249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage in cyclophosphamide-resistant tumor cells: the role of glutathione.
    Richardson ME; Siemann DW
    Cancer Res; 1995 Apr; 55(8):1691-5. PubMed ID: 7712476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.